• Home
  • MEK/CDK4,6 co-targeting is effective in a subset of NRAS, BRAF and 'wild type' melanomas.

MEK/CDK4,6 co-targeting is effective in a subset of NRAS, BRAF and 'wild type' melanomas.

Author List
Posch C, Sanlorenzo M, Ma J, Kim ST, Zekhtser M, Ortiz-Urda S
Publication
Oncotarget
Publication ID (Profile URL)
https://researcherprofiles.org/profile/88522773
Publication Year
2018
PubMed ID
30405888
Publication Title
Posch C, Sanlorenzo M, Ma J, Kim ST, Zekhtser M, Ortiz-Urda S. MEK/CDK4,6 co-targeting is effective in a subset of NRAS, BRAF and 'wild type' melanomas. Oncotarget. 2018 Oct 09; 9(79):34990-34995.